US Patent Issued to Societe des Produits Nestle on Oct. 14 for "Composition for use in improving endothelial function by enhancing flow mediated dilation" (Singaporean, Swiss Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,531, issued on Oct. 14, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).

"Composition for use in improving endothelial function by enhancing flow mediated dilation" was invented by Lucas Actis Goretta (Singapore) and Rachid Bel-Rhlid (Savigny, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition comprising esterase treated decaffeinated green coffee extract (HDGCE) for use in a method of improving cardiovascular endpoints such as endothelial function by enhancing flow mediated dilation in a subject, wherein the subject is administered an effective dose of HDGCE with an amount...